When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NVO - 4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
Novo Nordisk A/S
Danish pharmaceutical giant, Novo Nordisk (NYSE: NVO) made a lot of headlines recently with a big buyout offer for Dicerna Pharmaceuticals (NASDAQ: DRNA) . Novo Nordisk offered Dicerna shareholders a great big 80% premium , leading investors to wonder which biotech stock might be next.
For good reasons, Arrowhead Pharmaceuticals (NASDAQ: ARWR) is a prime candidate for the next big biotech buyout. Here are four of the most important ones.